Skip to content

Screener

Eligibility screening

DASH Trial: Testing Ceralasertib and Trastuzumab Deruxtecan

Sponsored by National Cancer Institute (NCI)Study detailsClinicalTrials.gov

23 US sites in CA, FL, IL, MD +7

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.